Skip to content
Search

Latest Stories

GPhC fitness to practise committee suspends a pharmacist for four months

The General Pharmaceutical Council (GPhC) Fitness to Practise Committee has suspended a pharmacist for four months after been found guilty of misconduct of removing bottles of codeine linctus without pharmacy owner's permission.

The Committee was of the view that an order of suspension was the appropriate and proportionate sanction to send an appropriate and clear message to professionals and to the public of the seriousness with which the regulator takes the pharmacist's misconduct.


"This will ensure that the public can continue to have confidence in the profession, uphold professional standards and maintain the public’s confidence in the Regulator itself," said committee.

Abdalla Mohammed Abdallo a pharmacist first registered on 15 August 2014 with the General Pharmaceutical Council under the registration number 2083625. On 27 October 2020, whilst working as a locum pharmacist at Tuebrook Pharmacy, the pharmacist ordered four 200ml bottles of codeine linctus SF and removed four 200ml bottles of codeine linctus SF from Tuebrook Pharmacy without making payment.

On 28 October 2020, whilst working as a locum pharmacist at Upton Rocks Pharmacy, he ordered four bottles of 200ml codeine linctus BP; removed 4 bottles of 200ml codeine linctus BP from Upton Pharmacy without making payment. He also removed four 200ml codeine linctus BP from Upton Pharmacy without permission from the owner.

In relation to the appropriate length of suspension, the Committee took into account the pharmacist’s difficult personal circumstances at the time. The Committee alsoexpressed the view that these matters do not excuse his misconduct, however they are mitigating factors.

The Committee has also taken into account that the pharmacist has been subject to interim orders for over two years, and for the majority of that time he has been subject to interim suspension.

Therefore, the Committee decided that a short period of suspension of four months is appropriate and proportionate in all the circumstances. The hearing was conducted on 13-16 March 2023 & 6-8 June 2023.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less